Skip Header to Content
GLAD Logo GLAD Logo Skip Primary Navigation to Content
  • By Issue
    Close
  • By Location
    Close
  • By Type
    Close
Go

Improving Access to PrEP in Rhode Island

Pending

Overview

Rhode Island’s H6150 will expand access to pre-exposure prophylaxis (PrEP) – a game-changing medication that reduces the risk of HIV transmission by close to 100 percent.

H6150 lets pharmacists provide a patient with a short-term supply (60 days once in a two-year period) of PrEP without a prescription. Pharmacists will be required to provide counseling on the use of PrEP and connect patients without a primary care provider with health care providers for ongoing medication and care.

H6150 also requires insurers to cover one type of PrEP within each method of administration without cost-sharing or prior authorization. These provisions are critical but should go further in order to remove obstacles to PrEP.

Learn more: Read our testimony with Youth Pride, INC., SHIP, and LGBTQ Action RI.

Related Documents